Jean-Philippe Collet

Showing 1-9 of 9 articles

Coronary interventions

Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: A CULPRIT-SHOCK angiographic substudy

Overtchouk P, Barthelemy O, Hauguel-Moreau M, Guedeney P, Rouanet S, Zeitouni M, Silvain J, Collet J-P, Vicaut E, Zeymer U, Desch S, Thiele H, Montalescot G, Bertin B, Brugier D, Vignolles N, Hage G, El Kasty M, Kerneis M, Huber K, Sandri M, Noc M, Fuernau G

July 7, 2020 | 10.4244/EIJ-D-20-00139

Coronary interventions

Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis

Collet J-P, Kerneis M, Lattuca B, Yan Y, Cayla G, Silvain J, Lapostolle F, Ecollan P, Diallo A, Vicaut E, Hamm C, van’t Hof A, Montalescot G

September 20, 2018 | 10.4244/EIJ-D-18-00182

STEMI

The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis

Bellemain-Appaix A, Begue C, Bhatt D, Ducci K, Harrington R, Roe M, Wiviott SD, Cucherat M, Silvain J, Collet J-P, Bernasconi F, Montalescot G

May 20, 2018 | 10.4244/EIJ-D-17-00852

Interventions for heart failure

Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support

Overtchouk P, Pascal J, Lebreton G, Hulot J-S, Luyt C-E, Combes A, Kerneis M, Silvain J, Barthelemy O, Leprince P, Brechot N, Montalescot G, Collet J-P

April 6, 2018 | 10.4244/EIJ-D-17-01014

Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures

Guedeney P, Hammoudi N, Duthoit G, Yan Y, Silvain J, Pousset F, Isnard R, Redheuil A, Kerneis M, Collet J-P, Montalescot G

November 20, 2017 | 10.4244/EIJ-D-17-00518

Interventions for valvular disease

Antithrombotic therapy in TAVI patients: changing concepts

Gargiulo G, Collet J-P, Valgimigli M

September 17, 2015 | 10.4244/EIJV11SWA28

Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement

Capodanno D, Lip G, Windecker S, Huber K, Kirchhof P, Boriani G, Lane D, Gilard M, Collet J-P, Valgimigli M, Byrne R

January 22, 2015 | 10.4244/EIJV10I9A174

2014 ESC/EACTS Guidelines on myocardial revascularization

Windecker S, Kolh P, Alfonso F, Collet J-P, Cremer J, Falk V, Filippatos G, Hamm C, Head S, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann F, Richter D, Schauerte P, Uva M, Stefanini G, Taggart D, Torracca L, Valgimigli M, Wijns W, Witkowski A

January 22, 2015 | 10.4244/EIJY14M09_01

Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?

Collet J-P, Montalescot G

September 15, 2013 | 10.4244/EIJV9SSA9

1

Latest news

Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...

Optimising the delivery of self-expanding valves according to vascular access

November 20, 2020

Fatal Acute Mesenteric Ischemia Following Transcatheter Aortic Valve Replacement

November 25, 2020

Patient preferences and Heart Team decision

November 20, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Cardiovascular trials and COVID-19

Alexandra Lansky

November 25, 2020

This Week's JAA's: Win Ratio for Renal Denervation, Optimal strategy for NSTEMI in the very elderly, D-PUSH OCT Procedure...

November 24, 2020

Valvular disease